Better Med-Surgical, Tribes & Tech: U.S. Pat. 8,688,471

For better med-surgical -- fresh solutions via the 1st tribal-based, USPTO-issued advanced technology patent (U.S. Pat. 8,688,471)

Our solution is our pioneer U.S. Pat. 8,688,471, the first advanced technology USPTO patent sited upon sovereign, federally-recognized, and constitutionally-cited American Indian/Alaskan Native tribal lands.

As a pioneering and innovative technology, our indigenous tribal-based patent 471 technlogy’s goal is to make med-surgical systems (education and practice) more affordable and more accessible -- by helping enable other technologies, such as blockchain and A.I., to be expedited for implementation.

Outcome: increase the supply of, and access to, med-surgical that is measurably more affordable.

To us, our tribal-based patent ‘471 is a meta-technology — a technology that is an active platform for expediting other technologies (e.g., A.I. and blockchain, including supply chains).

That is, “clean-sheet thinking,” for “green-field opportunities.”

"PAIN POINT"

It has been widely reported that for many reasons over 20+ years, USA med-surgical can be top-tier care — or the slowest — and certainly the most-costly.

That is, such uneven outcomes, despite the USA funding >45% of global medical research. Calls for “medical tourism” abound.

Concurrently, sovereign and indigenous "Indian Country" (567 federally-recognized/treaty tribal nations) and their Rural America neighbors have endured service-delivery issues. We understand tribal sovereignty and Rural America -- our families have collaborated with them for 100+ years.

Similarly, across the world, efficacious distribution of med-surgical and cost of care are of great concern. Inefficient, uneven distribution of resources generally results in other patients not being treated efficaciously -- or zero care.

SOLUTION

Given the increasingly distressing USA med-surgical cost/quality downward spiral -- we invented tribal-based, time-limited patent ‘471, to make med-surgical more productive/affordable and help patients contain related financial issues.

Our indigenous-based patent ‘471 technology posits that with its novel, non-obvious combination of available elements, ‘471 can be an active platform for fresh, clear-eyed construction of new med-surgical systems (education and practice), providing more affordable and more accessible care.

Key '471 factor: the federally-recognized and constitutionally-guaranteed sovereignty for self-determination that indigenous tribal nations have, to set regulations and laws that fit their tribal-nation’s culture.

As in scenes in "Old West cowboy" films when U.S. marshals say, “well, that’s Indian territory, that’s their jurisdiction.” As in, the $28 billion tribal hospitality/gaming industry, a sovereign tribal activity within USA borders.

Thus, per patent ‘471's issuance — with the support of indigenous sovereignty and global technologies and staffing, ‘471-driven institutions can sweep away deeply-entrenched impediments to affordability/productivity and access. Examples:

• thoughtful tribal legal structures that (1) fairly treat patients while (2) appropriately regulating medical-malpractice lawyers, now mass advertising in Britain
• non-collaborative work-culture “silos” that confuse patients and financially burden supply chains, others

As a result, care communities can expedite forward, new technologies (e.g., blockchain, A.I.) and the best in med-surgical systems.

Consider this patent '471 scenario, about the proven shortage of female leadership in USA medicine.

A ‘471-driven med-surgical system could expedite a new, female-led med-surgical education/practice cooperative (see following, Heinz/Biden funding). To be clear: not innovation after years of debate -- STAT.

GLOBAL IMPACT

The USA funds <45% of global medical research. By making USA med-surgical more affordable/productive and more accessible via advanced technology and innovative U.S. Pat. 8,688,471 — global medicine be improved as a result.

Our solution, our pioneer tribal-based U.S. Pat. 8,688,471, endured one of most-detailed USPTO exams ever, involving top federal officials. Thus, many would believe that validates patent '471 technology as “innovative.”

Indigenous-based '471 is the first advanced-technology invention focused on sovereign, federally-recognized/treaty tribes (n=567), issued a USPTO patent. Our families have collaborated with indigenous tribes for 100+ years, which made '471 technology novel to USPTO.

'471 is a non-obvious system comprised of affordable elements. Akin to the Wright Brothers, '471 was produced/patented with our personal resources.

We patented ‘471, to produce a few successful launches -- versus 30+ under-funded failures.

An active, clean-sheet tech-platform for freshly-considered approaches to med-surgical education and practice, our pioneering U.S. Pat. 8,688,471 can expedite new technologies, for more affordable/more accessible med-surgical. That includes blockchain and A.I. technologies.

We strongly believe that blockchain technology can help bring order to the oft-chaotic world of med-surgical, including supply chain and patient care coordination.

A.I. technology can help communities care for patients -- communities care the most. And help to decide when to contact providers.

And with no installed base to deal with -- via tribal-based '471 technology, new technologies can be implemented smoothly and cost-effectively (e.g., green-field).

We will continue these long-standing goals --

• Staffing -- many of our indigenous-tribal-based patent '471 technology team (including volunteers) have reached retirement eligibility. Succession by highly-experienced and accomplished staff is top-of-mind. 
• Fund-raising among major entities (e.g., Ireland EDC) and major investors. Med-surgical is capital-intensive, and so requires major efforts. Examples: the lawyers in a Heinz-Biden-Kerry <$200MM fund for New Mexico and Idaho, now tied to Rice University; also in a separate <$105MM Denver-area investment.
• Continue R&D for patients, including relations with USPTO.

Based on funding and our front-line med-surgical experiences, we envision creating 10+ geographically-dispersed care communities of ~100,000 persons/community, in five years.

To our view, larger groups can have dis-economies of scale that negatively affect patient care quality (e.g., Michigan State University/L. Nassar), while smaller ones do not have economies of scale for affordability. We prefer "smart growth," rather than nerve-stretching growth.

So, over five years, tribal-based patent '471 technology will reach 1+ million, directly and indirectly. Example: a female-led '471 med-surgical cooperative would engender more female leaders, impacting other med-surgical systems, globally.

We are already linked to groups globally (Asia, Europe, U.A.E.).

Our indigenous-based patent '471 technology has already strongly linked to indigenous tribal and Rural American leaders across North America via Internet technology, to forge workable and practical solutions that are locally-focused, productive, accessible, and affordable.

And as every community (e.g., tribal) is unique, we are very "hands on" with each community — listening carefully to their unique cultural cues and then recommending implementation options to their leaders.

As to final implementation -- to our view, it is up to local leaders to make final decisions, as they are sovereign.

Our patent '471 populations are diverse, from tribes to middle-class struggling with finances.

To us, as creators of the first advanced-technology invention focused on indigenous American Indian/Alaskan Native lands — we believe patent '471 technology has had a meaningful/positive impact/influence on hundreds of thousands in “Indian Country,” its neighbors Rural America, and the world. Our goal has been, and will be, these diverse groups collaborate for med-surgical that is more affordable and more accessible.

Put succinctly, by themselves, many groups have small service-demand — so collaborating aggregates demand to make regionalized med-surgical systems (education & practice) practical.

As noted, our indigenous-based patent '471 populations are diverse (e.g., tribes, middle-class workers). Common affect for patients: more affordable med-surgical, by collaborating peacefully.

If supported, within 12 months (based on initial expectations) -- we anticipate positively affecting the lives of ~200,000+, as we go full-on public with our development/implementation plans, and directly in ~2 communities. We would empower communities across the world, by giving them more voice in patient care.

In three years, that would expand to ~600,000+, in ~6 communities.

As noted -- our goals include maintaining optimal productivity. In our experiences, managing demand to expectations is a key factor.

We offer everyone and the Solve/M.I.T. community, what we offer tribal and Rural America communities:

• Very willing to collaborate, in a manner that is mutually respectful, productive and positive. Again, our families have 100+ years of collaborating with tribes.
• Very willing to share fairly, in the view of objective third-parties.
• Disclose fairly, quickly, frankly and diplomatically.
• True and deep desire to make med-surgical more affordable and more accessible.
• Strongly-experienced and accomplished management, including technology and finance. Work experiences include expediting inter-connection of $100MM data-centers and Business Week 1000 public companies (C-level). Top-tier MBA degrees.

In brief: for the present time, our policy is to follow USA med-surgical revenue models for education and practice (non-profit and investor-owned). We are open to any recommendations on revenue models that have intellectually-rigorous rationale and financial detail, in writing.

Upon experience, information and belief -- to our view, existing USA revenue models have created price umbrellas sufficient for our long-term sustainability and growth, including our goal of greater affordability/accessibility for patients. And even with our policy of full and fair disclosure of financial details.

We have been, and will be, financially sustainable and able to grow because we strongly expect resources to be managed alertly and prudently. Today, the tribal-based pioneer patent '471 technology has zero debt and is financially unencumbered, and we have 100% ownership/control.

A major factor in our application: age. Many of our tribal-based pioneer patent '471 team (incl. volunteers) have reached retirement eligibility. Via Solve/M.I.T. community, we believe we can gain access to highly-experienced and accomplished successors.

And M.I.T. being a global Top 5 engineering/MBA institution is also helpful, to the first advanced technology USPTO patent sited on tribal lands — a self-evident factor.

To our view, we need more R&D and legal, engineering, MBA-level support for forecasting, and management.

And that Solve's objectives herein, align with our indigenous-based patent '471 technology, is very positive.

#1: Staffing -- many of our team (incl. volunteers) have reached retirement eligibility. Solve/M.I.T. factor: younger.

#2: Financing -- med-surgical is capital-intensive, relying on major investors (Heinz/Biden, op. cit.) and major entities (Ireland EDC, op. cit.). M.I.T. is proven fund-raiser.

#3: Intellectual rigor & "heart" -- implementing a new and meaningful med-surgical platform is intellectually-challenging & psychologically-tough work of heart and mind. Your team is among the best, to us.

#4: Institutional support -- some have been vocally-sharp with critiques of tribal/rural abilities. Thanks to our diverse, loyal community, we are still here. Solve/M.I.T. support would help placate such critics, to our view.